Detection of ctDNA with Personalized Molecular Barcode NGS and Its Clinical Significance in Patients with Early Breast Cancer

We attempted to detect circulating tumor DNA (ctDNA), taking advantage of molecular barcode next-generation sequencing (MB-NGS), which can be more easily customized to detect a variety of mutations with a high sensitivity than PCR-based methods. Sequencing with a gene panel consisting of the 13 most...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshinami, Tetsuhiro, Kagara, Naofumi, Motooka, Daisuke, Nakamura, Shota, Miyake, Tomohiro, Tanei, Tomonori, Naoi, Yasuto, Shimoda, Masafumi, Shimazu, Kenzo, Kim, Seung Jin, Noguchi, Shinzaburo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260577/
https://www.ncbi.nlm.nih.gov/pubmed/32473569
http://dx.doi.org/10.1016/j.tranon.2020.100787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260577/
https://www.ncbi.nlm.nih.gov/pubmed/32473569
http://dx.doi.org/10.1016/j.tranon.2020.100787

Ejemplares similares